Literature DB >> 22092580

A novel mutation of the glomulin gene in an Italian family with autosomal dominant cutaneous glomuvenous malformations.

Riccardo G Borroni, Nupoor Narula, Marta Diegoli, Maurizia Grasso, Monica Concardi, Renato Rosso, Alessandra Cerica, Valeria Brazzelli, Eloisa Arbustini.   

Abstract

Glomuvenous malformations (GVM) are hamartomas characterized histologically by glomus cells, which should be distinguished from glomus tumors. Familial GVM are rare, often present as multiple lesions, and exhibit familial aggregation, with autosomal dominant transmission. GVM are caused by mutations of the glomulin (GLMN) gene on chromosome 1p21-p22. Their development is thought to follow the 'two-hit' hypothesis, with a somatic mutation required in addition to the inherited germline mutation. We describe a novel GLMN mutation in an Italian family with GVM in which some members present with the less commonly observed phenotype of solitary lesions. A second somatic 'hit' mutation in GLMN was not discovered in our family. We further provide histological, immunohistochemical and electron microscopic data exhibiting the classic features of GVM. The diagnosis of GVM is critical because of distinction from venous malformations and blue rubber bleb nevus syndrome, which may demonstrate clinical similarities but require different treatment.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092580     DOI: 10.1111/j.1600-0625.2011.01387.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  3 in total

Review 1.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

2.  Genotypes and phenotypes of 162 families with a glomulin mutation.

Authors:  P Brouillard; L M Boon; N Revencu; J Berg; A Dompmartin; J Dubois; M Garzon; S Holden; L Kangesu; C Labrèze; S A Lynch; C McKeown; R Meskauskas; I Quere; S Syed; P Vabres; M Wassef; J B Mulliken; M Vikkula
Journal:  Mol Syndromol       Date:  2013-03-26

3.  Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface.

Authors:  David M Duda; Jennifer L Olszewski; Adriana E Tron; Michal Hammel; Lester J Lambert; M Brett Waddell; Tanja Mittag; James A DeCaprio; Brenda A Schulman
Journal:  Mol Cell       Date:  2012-06-28       Impact factor: 17.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.